We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.7B
AUM Growth
-$178M
Cap. Flow
-$1.14B
Cap. Flow %
-8.27%
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 26.03%
2 Healthcare 12.56%
3 Financials 11.14%
4 Consumer Discretionary 11.02%
5 Industrials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYRA icon
2526
Tyra Biosciences
TYRA
$1.49B
$131K ﹤0.01%
7,702
OPRX icon
2527
OptimizeRx
OPRX
$165M
$131K ﹤0.01%
9,158
PANL icon
2528
Pangaea Logistics
PANL
$494M
$131K ﹤0.01%
+19,296
New +$119K
MCBC
2529
DELISTED
Macatawa Bank Corp
MCBC
$130K ﹤0.01%
14,024
SVRA icon
2530
Savara
SVRA
$1.09B
$130K ﹤0.01%
+40,543
New +$95.3K
GBTG icon
2531
American Express Global Business Travel
GBTG
$4.94B
$129K ﹤0.01%
+17,828
New +$121K
AMPY icon
2532
Amplify Energy
AMPY
$203M
$129K ﹤0.01%
18,986
CPS icon
2533
Cooper-Standard Automotive
CPS
$484M
$128K ﹤0.01%
+9,000
New +$110K
OSG
2534
DELISTED
Overseas Shipholding Group Inc.
OSG
$128K ﹤0.01%
+30,577
New +$118K
SRTA
2535
Strata Critical Medical Inc
SRTA
$531M
$127K ﹤0.01%
32,344
IPI icon
2536
Intrepid Potash
IPI
$480M
$127K ﹤0.01%
5,611
PEGA icon
2537
Pegasystems
PEGA
$5.53B
$127K ﹤0.01%
5,150
+142
+3% +$3.3K
XFOR icon
2538
X4 Pharmaceuticals
XFOR
$433M
$127K ﹤0.01%
+2,181
New +$112K
NOTE
2539
DELISTED
FiscalNote
NOTE
$127K ﹤0.01%
+2,901
New +$81.5K
MVBF icon
2540
MVB Financial
MVBF
$394M
$127K ﹤0.01%
6,009
AKTS
2541
DELISTED
Akoustis Technologies Inc
AKTS
$126K ﹤0.01%
39,725
+7,313
+23% +$22.4K
MAX icon
2542
MediaAlpha
MAX
$812M
$126K ﹤0.01%
12,251
ORGO icon
2543
Organogenesis Holdings
ORGO
$230M
$126K ﹤0.01%
38,025
ICVX
2544
DELISTED
Icosavax, Inc. Common Stock
ICVX
$126K ﹤0.01%
12,698
FBIZ icon
2545
First Business Financial Services
FBIZ
$595M
$126K ﹤0.01%
4,273
JANX icon
2546
Janux Therapeutics
JANX
$986M
$126K ﹤0.01%
10,614
GRND icon
2547
Grindr
GRND
$2.74B
$125K ﹤0.01%
+22,680
New +$138K
KOD icon
2548
Kodiak Sciences
KOD
$2.54B
$125K ﹤0.01%
18,141
BLNK icon
2549
Blink Charging
BLNK
$87.1M
$125K ﹤0.01%
20,880
SPOK icon
2550
Spok Holdings
SPOK
$230M
$124K ﹤0.01%
+9,363
New +$117K

Similar funds

MetLife Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.

  • MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
  • MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
  • MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
  • MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
  • MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
  • MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.